Target Genes: Bone Proteins

Vitamin D

Volumn 1, Issue , 2005, Pages 711-720

  Atkins, Gerald J ^a   Findlay, David ^b   Anderson, Paul H ^c   Morris, Howard A ^a  

^a HANSON INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947189419     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012252687-9/50044-9     Document Type: Chapter

References (96)

1. Fukugawa M, Kurokawa K Calcium homeostasis and imbalance. Nephron 2002, 92:41-45.
2. Parfitt AM, Han ZH, Palnitkar S, Rao DS, Shih MS, Nelson D Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone. J Bone Miner Res 1997, 12:1864-1873.
3. 3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
4. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998, 139:4391-4396.
5. Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberherr M, Gniadecki R, Moller G, Adamski J, Balling R Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 2002, 16:1524-1537.
6. Dardenne O, Prud'homme J, Hacking SA, Glorieux FH, St-Arnaud R Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1). Bone 2003, 32:332-340.
7. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 1999, 140:4982-4987.
8. 3: Biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res 2003, 18:637-643.
9. Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, Goltzman D Inactivation of the 25-hydroxyvitamin D-1α-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004, 279:16754-16766.
10. van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr 2001, 11:199-226.
11. Suda T, Ueno Y, Fujii K, Shinki T Vitamin D and bone. J Cell Biochem 2003, 88:259-266.
12. Langdahl BL, Mortensen L, Vesterby A, Eriksen EF, Charles P Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone 1996, 18:103-108.
13. Eriksen EF, Steiniche T, Mosekilde L, Melsen F Histomorphometric analysis of bone in metabolic bone disease. Endocrinol Metab Clin North Am 1989, 18:919-954.
14. Robey GP, Boskey AL Extracellular matrix and biomineralization of bone. In: Favus MJ (ed) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. American Society for Bone and Mineral Research, Washington, DC, pp. 38-46.
15. 3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells. Bone 1991, 12:27-32.
16. 3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells. Bone 1995, 16:671-678.
17. Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findlay DM, Zannettino AC RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 2003, 18:1088-1098.
18. Sodek J, Li JJ, Kim RH, Ogata Y, Yamauchi M Characterization of the bone sialoprotein (BSP) gene promoter. Connect Tissue Res 1996, 35:23-31.
19. Owen TA, Bortell R, Yocum SA, Smock SL, Zhang M, Abate C, Shalhoub V, Wright KL, van Wijnen AJ, et al. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: Model for phenotype suppression of transcription. Proc Natl Acad Sci USA 1990, 87:9990-9994.
20. Siggelkow H, Rebenstorff K, Kurre W, Niedhart C, Engel I, Schulz H, Atkinson MJ, Hufner M Development of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem 1999, 75:22-35.
21. Stein GS, Lian JB, Stein JL, Van Wijnen AJ, Montecino M Transcriptional control of osteoblast growth and differentiation. Physiol Rev 1996, 76:593-629.
22. Gerstenfeld LC, Chipman SD, Glowacki J, Lian JB Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol 1987, 122:49-60.
23. Choi JY, Lee BH, Song KB, Park RW, Kim IS, Sohn KY, Jo JS, Ryoo HM Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells. J Cell Biochem 1996, 61:609-618.
24. 3. Proc Natl Acad Sci USA 1981, 78:4990-4994.
25. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T 1α,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J 1982, 204:713-719.
26. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000, 15:2-12.
27. Simmons PJ, Torok-Storb B Identification of stromal cell presursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78:55-62.
28. Thomas GP, Baker SU, Eisman JA, Gardiner EM Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 2001, 170:451-460.
29. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM Role of CBP/P 300 in nuclear receptor signalling. Nature 1996, 383:99-103.
30. Glass CK, Rose DW, Rosenfeld MG Nuclear receptor coactivators. Curr Opin Cell Biol 1997, 9:222-232.
31. Kitazawa R, Kitazawa S, Maeda S Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim Biophys Acta 1999, 1445:134-141.
32. Stern PH Vitamin D and bone. Kidney Int Suppl 1990, 29:S17-S21.
33. 3. Cirt Rev Eukaryot Gene Expr 2001, 11:299-317.
34. Skjodt H, Gallagher JA, Beresford JN, Couch M, Poser JW, Russell RG Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro. J Endocrinol 1985, 105:391-396.
35. 3-analogs on osteoblast-like cells and on vitro bone resorption. J Steroid Biochem Mol Biol 1995, 55:337-346.
36. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: Dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat ostoblast cultures. Endocrinology 1991, 128:1496-1504.
37. 3 regulation of proliferation and alkaline phosphatase activity in late-passage rat osteoblastic cell lines. J Steroid Biochem Mol Biol 1993, 46:227-233.
38. 3 and glucocorticoids on the growth of rat and mouse osteoblast-like bone cells. Calcif Tissue Int 1983, 35:806-811.
39. 3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes. Biochem Biophys Res Commun 1993, 190:529-535.
40. 3. Calcif Tissue Int 1996, 59:291-296.
41. Lyons AB, Parish CR Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994, 171:131-137.
42. 3 in human osteosarcoma cells. J Biol Chem 1988, 263:18938-18945.
43. 3. J Biol Chem 1982, 257:8009-8015.
44. 3 and inhibited by human recombinant TIMP (tissue inhibitor of metalloproteinases). Biochem Biophys Res Commun 1987, 148:596-602.
45. 3. Cell Tissue Res 1999, 297:249-259.
46. 3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts. J Cell Biochem 1995, 57:440-451.
47. Yoon K, Buenaga R, Rodan GA, Prince CW, Butler WT Tissue specificity and developmental expression of rat osteopontin. Biochem Biophys Res Commun 1987, 148:1129-1136.
48. 3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 1994, 39:941-947.
49. 3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells. Coll Relat Res 1987, 7:305-313.
50. 3 in rat bone organ cultures. Connect Tissue Res 1996, 34:41-51.
51. 3 enhancement of osteopontin gene expression. Bone 1997, 20:329-334.
52. Noda M, Rodan GA Transcriptional regulation of osteopontim production in rat osteoblast-like cells by parathyroid hormone. J Cell Biol 1989, 108:713-718.
53. 3 enhacement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology 1996, 137:2001-2011.
54. Ganss B, Kim RH, Sodek J Bone sialoprotein. Crit Rev Oral Biol Med 1999, 10:79-98.
55. Oldberg A, Jirskog-Hed B, Axelsson S, Heinegard D Regulation of bone sialoprotein mRNA by steroid hormones. J Cell Biol 1989, 109:3183-3186.
56. Li JJ, Sodek J Cloning and characterization of the rat bone sialoprotein gene promoter. Biochem J 1993, 289:625-629.
57. Kim RH, Li JJ, Ogata Y, Yamauchi M, Freedman LP Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene. Biochem J 1996, 318:219-226.
58. Sodek J, Kim RH, Ogata Y, Li J, Yamauchi M, Zhang Q, Freedman LP Regulation of bone sialoprotein gene transcription by steroid hormones. Connect Tissue Res 1995, 32:209-217.
59. 3 stimulates synthesis and secretion of nonphosphorylated osteopontin (secreted phosphoprotein 1) in mouse JB6 epidermal cells. Cancer Res 1991, 51:2144-2150.
60. Pockwinse SM, Stein JL, Lian JB, Stein GS Developmental stage-specific cellular responses to vitamin D and glucocorticoids during differentiation of the osteoblast phenotype: Interrelationship of morphology and gene expression by in situ hybridization. Exp Cell Res 1995, 216:244-260.
61. Price PA, Williamson MK, Lothringer JW Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 1981, 256:12760-12766.
62. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382:448-452.
63. Chenu C, Colucci S, Grano M, Zigrino P, Barattolo R, Zambonin G, Baldini N, Vergnaud P, Delmas PD, Zallone AZ Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol 1994, 127:1149-1158.
64. Watts NB Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999, 45:1359-1368.
65. Ivaska KK, Hentunen TA, Vaaraniemi J, Ylipahkala H, Pettersson K, Vaananen HK Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 2004, 279:18361-18369.
66. 3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res 1985, 5:229-234.
67. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G, Stein G Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 1989, 86:1143-1147.
68. Lajeunesse D, Kiebzak GM, Frondoza C, Sacktor B Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Miner 1991, 14:237-250.
69. 3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Differentiation 1994, 55:153-163.
70. Bodine PV, Trailsmith M, Komm BS Development and characterization of a conditionally transformed adult human osteoblastic cell line. J Bone Miner Res 1996, 11:806-819.
71. 3.574.1905 A67. Arch Biochem Biophys 1996, 332:142-152.
72. Hicok KC, Thomas T, Gori F, Rickard DJ, Spelsberg TC, Riggs BL Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res 1998, 13:205-217.
73. Lajeunesse D, Frondoza C, Schoffield B, Sacktor B Osteocalcin secretion by the human osteosarcoma cell line MG-63. J Bone Miner Res 1990, 5:915-922.
74. Hosoda K, Kanzaki S, Eguchi H, Kiyoki M, Yamaji T, Koshihara Y, Shiraki M, Seino Y Secretion of osteocalcin and its propeptide from human osteoblastic cells: Dissociation of the secretory patterns of osteocalcin and its propeptide. J Bone Miner Res 1993, 8:553-565.
75. 3 inhibits osteocalcin expression in mouse through an indirect mechanism. J Biol Chem 1997, 272:110-116.
76. Lian JB, Shalhoub V, Aslam F, Frenkel B, Green J, Hamrah M, Stein GS, Stein JL Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: Dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 1997, 138:2117-2127.
77. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T Targeted disruption of Cbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
78. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ Cbfal, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
79. Javed A, Gutierrez S, Montecino M, van Wijnen AJ, Stein JL, Stein GS, Lian JB Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization. Mol Cell Biol 1999, 19:7491-7500.
80. Aslam F, McCabe L, Frenkel B, van Wijnen AJ, Stein GS, Lian JB, Stein JL AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: Requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation. Endocrinology 1999, 140:63-70.
81. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 1993, 122:685-701.
82. McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR Developmental expression and activaties of specific fos and jun proteins are functionally related to osteoblast maturation: Role of Fra-2 and Jun D during differentiation. Endocrinology 1996, 137:4398-4408.
83. Narisawa S, Frohlander N, Millan JL Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 1997, 208:432-446.
84. Noda M, Yoon K, Rodan GA, Koppel DE High lateral mobility of endogenous and transfected alkaline phosphatase: A phosphatidylinositol-anchored membrane protein. J Cell Biol 1987, 105:1671-1677.
85. 3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 1981, 256:7115-7117.
86. Imai K, Neuman MW, Kawase T, Saito S Calcium in osteoblast-enriched bone cells. Bone 1992, 13:217-223.
87. Halstead LR, Scott MJ, Rifas L, Avioli LV Characterization of osteoblast-like cells from normal adult rat femoral trabecular bone. Calcif Tissue Int 1992, 50:93-95.
88. El-Maadawy S, Kaartinen MT, Schinke T, Murshed M, Karsenty G, McKee MD Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res 2003, 44:272-278.
89. 3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines. J Biol Chem 1988, 263:911-916.
90. 3 treatment of osteosarcoma cells. Calcif Tissue Int 1990, 46:270-279.
91. Barone LM, Owen TA, Tassinari MS, Bortell R, Stein GS, Lian JB Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis. J Cell Biochem 1991, 46:351-365.
92. Hewison M, Zehnder D, Bland R, Stewart PM 1α-Hydroxylase and the action of vitamin D. J Mol Endocrinol 2000, 25:141-148.
93. 3. Biochemistry 1983, 22:1073-1076.
94. Atkins GJ, Anderson PH, Morris HA, Zannettino ACW, Kostakis P, Findlay DM The expression of 25-hydroxyvitamin D 24-hydroxylase and 25-hydroxyvitamin D 1α-hydroxylase in human osteoblasts. J Bone Miner Res 2003, 18(Suppl. 2):M480.
95. Ke HZ, Qi H, Crawford DT, Xu G, Li M, Plum L, Clagett-Dame M, DeLuca HF, Thompson DD, Brown TA A novel vitamin D analogue restores bone mass and adds extra bone by markedly stimulating bone formation in ovariectomized rats with established osteopenia. J Bone Miner Res 2003, 18(Suppl. 2):1153.
96. Robey GP, Boskey AL Extracellular matrix and biomineralization of bone. In: Favus MJ (ed) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. American Society for Bone and Mineral Research, Washington, DC, pp. 38-46.